PlaqueTec and the Babraham Institute collaborate on early phase target discovery and development

FHS
May 14, 2024
9:59 am

Campus Innovation Award (CIA)-funded project evaluated lead compounds predicted to bind a pro-inflammatory protein discovered by PlaqueTec

Takeda pulls dengue vaccine application after FDA requests more data

Takeda has withdrawn an FDA application for its dengue vaccine candidate following a request by regulators for more data. The Japanese biotech filed a biologics

July 12, 2023

Mindbio Announces Clinical Trial Milestone In Phase 2B Microdosing Trials Targeting Existential Distress, Depression & Anxiety In Advanced Stage Cancer | Psychedelic Invest

Vancouver, British Columbia – October 24, 2024 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6), (the “Company” or “MindBio”), a leading biopharmaceutical company in psychiatric medicine development, targeting depressive

October 24, 2024

Cervical Length Screening Did Not Reduce Rates of Preterm Births

NATIONAL HARBOR, Md. — Among pregnant women at low risk for preterm delivery, universal transvaginal ultrasound (TVU) cervical length screening did not reduce rates of

February 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.